Arkolith/Insider Trading/LSTA/Form 4

Mazzo David J

Chief Executive Officer, DirectorLISATA THERAPEUTICS, INC. (LSTA) · full profile →Form 4 · filed Jan 11, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
5
4 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 10, 2024Tax withholding(F)3K$3.00$10K176K
Jan 9, 2024Grant(A)94K—$0199K
Jan 9, 2024Tax withholding(F)8K$3.08$24K179K
Jan 9, 2024Tax withholding(F)12K$3.08$38K187K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 9, 2024Grant(A)47K—$047K

Transaction Codes

F
Shares withheld for taxes
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001334549-24-000002) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML